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Experimental section
General information
Reaction yields are not optimized. All reagents obtained from commercial sources were used without purification. Melting point: Gallenkamp Melting Point Apparatus MPD350.BM2.5 with digital thermometer/uncorrected. IR (KBr disk or thin film): Nicolet 320 FT spectrophotometer. 1 H NMR: Varian Gemini 300 (300 MHz), Mercury 400 (400 MHz) and Inova 500 (500 MHz) spectrometers at 298 K. Chemical shifts were referenced and expressed in ppm () relative to the central peak of TMS for chloroform-d. 13 was used as a high-throughput flash purification system.
Materials
, 6-nitroindan-1-one (13) [1] , 2-(5-nitro-1H-inden-3-yl)acetic acid (14) [1] , and 2-(1,1-dimethyl-5-nitro-1H-inden-3-yl)acetic acid (22) [1] were prepared as previously described.
2-(2-Methyl-5-nitro-1H-inden-3-yl)ethanol (10)
To dry THF (30 mL) cooled to 0 °C, AlH 3 −NMe 2 Et (0.5 M in toluene, 7.10 mL, 3.54 mmol) was added. Then, a solution of acid 7 (0.75 g, 3.21 mmol) in dry THF (30 mL) cooled to 0 °C was added. At the end of the addition, the mixture was maintained at the same temperature under argon atmosphere for 2 h. The reaction was quenched with THF:H 2 O (1:1, 75 mL) and the temperature was allowed to rise slowly to room temperature. The resulting suspension was filtered through Celite ® . The layers were separated and the organic extract was washed with brine (3  50 mL), dried over anhydrous Na 2 SO 4 , filtered and evaporated to dryness. The residue obtained was purified by silica gel column chromatography (CH 2 Cl 2 :MeOH mixtures of increasing polarity as eluent).
Alcohol 10 was obtained as a yellow solid (154.0 mg, 22%).
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Mp 120−121 °C; IR (KBr disk): ν (OH) 3245; ν (NO 2 ) 1511, 1337 cm 
2'-Methyl-6'-nitrospiro[cyclopropane-1,1'-indene] (12)
To a stirred solution of compound 11 (80.0 mg, 0.21 mmol) in dry DMF (1.5 mL) was added a solution of dimethylamine (40% in water, 0.30 mL, 2.14 mmol) under argon atmosphere and the resulting mixture was stirred at room temperature for 21 h. Then, the mixture was concentrated in vacuum. The residue was dissolved with EtOAc (20 mL) and washed with water (3 × 15 mL 
Synthesis of 2-(5-nitro-1H-inden-3-yl)acetamides. General procedure
To a sufficient amount of dry THF cooled to −78 °C, a solution of lithium diisopropylamide (LDA,
equiv) was added, under argon atmosphere. Then, N,N-dimethylacetamide, N-acetylpyrrolidine
or N-acetylpiperidine (1.05 equiv) was added and the resulting mixture was stirred at −78 °C for 1 h. Finally, a solution of 2-methyl-6-nitroindan-1-one (6), 6-nitroindan-1-one (13) or 3,3-dimethyl-6-nitroindan-1-one (21) (1 equiv) in the sufficient amount of dry THF was added, and the resulting mixture was kept at -78 °C for 2 h. The reaction mixture was acidified with 1N HCl and extracted with EtOAc. The organic extracts were dried with anhydrous Na 2 SO 4 , filtered and evaporated to dryness. To a stirred solution of the previous residue in dry CH 2 Cl 2 , cooled to 0 °C, was added trifluoroacetic acid (7.0 equiv) and the resulting mixture was stirred for 2 or 17 h. The reaction mixture was evaporated to dryness. The residue obtained was basified with saturated NaHCO 3 aqueous solution and extracted with CH 2 Cl 2 . The organic extract, after being dried over anhydrous Na 2 SO 4 and filtered, was evaporated to dryness. The residue obtained was purified by silica gel column chromatography (CH 2 Cl 2 :EtOAc mixtures of increasing polarity as eluent).
N,N-Dimethyl-2-(2-methyl-5-nitro-1H-inden-3-yl)acetamide (8)
The above procedure was followed with N,N-dimethylacetamide (0.25 mL, 2.74 mmol), LDA (1.5 M in THF, 3.66 mL, 5.49 mmol), 2-methyl-6-nitroindan-1-one (6) (0.50 g, 2.61 mmol) in dry THF (30 mL) and TFA (1.70 mL) in dry CH 2 Cl 2 (25 mL) for 2 h. Acetamide derivative 8 (475 mg, S7 70%) was obtained as a yellow solid. The spectral data of 8 were identical to those previously reported [1] .
N,N-Dimethyl-2-(5-nitro-1H-inden-3-yl)acetamide (15)
The procedure described above was followed with N,N-dimethylacetamide (0.26 mL, 2.96 mmol), LDA (1.5 M in THF, 3.95 mL, 5.93 mmol), 6-nitroindan-1-one (13) (0.50 g, 2.82 mmol) in dry THF (30 mL) and TFA (1.51 mL) in dry CH 2 Cl 2 (25 mL) for 2 h. Acetamide derivative 15 (451 mg, 65%) was obtained as a yellow solid. The spectral data of 15 were identical to those previously reported [1] .
2-(2-Methyl-5-nitro-1H-inden-3-yl)-1-(pyrrolidin-1-yl)ethanone (16)
The above procedure was followed with N-acetylpyrrolidine (0.30 mL, 2.75 mmol), LDA (1.5 M in THF, 3.66 mL, 5.49 mmol), 2-methyl-6-nitroindan-1-one (6) (0.50 g, 2.61 mmol) in dry THF (30 mL) and TFA (1.81 mL) in dry CH 2 Cl 2 (30 mL) for 17 h. Acetamide derivative 16 (550 mg, 74%) was obtained as a yellow solid. The spectral data of 16 were identical to those previously reported [1] .
2-(5-Nitro-1H-inden-3-yl)-1-(piperidin-1-yl)ethanone (17)
The above procedure was followed with N-acetylpiperidine (0.38 mL, 2.96 mmol), LDA (1.5 M in THF, 3.95 mL, 5.93 mmol), 6-nitroindan-1-one (13) (0.50 g, 2.82 mmol) in dry THF (30 mL) and TFA (1.81 mL) in dry CH 2 Cl 2 (25 m) for 17 h. Acetamide derivative 17 (627 mg, 78%) was obtained as a brown solid. The spectral data of 17 were identical to those previously reported [1] .
2-(2-Methyl-5-nitro-1H-inden-3-yl)-1-(piperidin-1-yl)ethanone (18)
The above procedure was followed with N-acetylpiperidine (0.35 mL, 2.75 mmol), LDA (1.5 M in THF, 3.66 mL, 5.49 mmol), 2-methyl-6-nitroindan-1-one (6) -1H-inden-3-yl)-1-(pyrrolidin-1-yl) 
